{{Rsnum
|rsid=2234636
|Gene=SLC39A2
|Chromosome=14
|position=21000992
|Orientation=plus
|GMAF=0.3163
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=RP11-84C10.4,SLC39A2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.8 | 41.6 | 49.6
| HCB | 11.8 | 50.7 | 37.5
| JPT | 23.0 | 44.2 | 32.7
| YRI | 0.7 | 25.9 | 73.5
| ASW | 3.5 | 38.6 | 57.9
| CHB | 11.8 | 50.7 | 37.5
| CHD | 11.9 | 50.5 | 37.6
| GIH | 8.9 | 49.5 | 41.6
| LWK | 0.0 | 11.8 | 88.2
| MEX | 27.6 | 50.0 | 22.4
| MKK | 5.1 | 42.3 | 52.6
| TSI | 12.7 | 45.1 | 42.2
| HapMapRevision=28
}}{{PMID Auto
|PMID=21947419
|Title=SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer
|OA=1
}}

{{GET Evidence
|gene=SLC39A2
|aa_change=Phe115Leu
|aa_change_short=F115L
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2234636
|overall_frequency_n=3135
|overall_frequency_d=10758
|overall_frequency=0.291411
|n_genomes=31
|n_genomes_annotated=0
|n_haplomes=37
|n_articles=0
|n_articles_annotated=0
|nblosum100=0
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}